Unveiling the Role of Glutathione S -transferase Protein in Breast Cancer Drug Resistance: Insights into the Signaling Pathways and Therapeutic Implications
ACS Pharmacology & Translational Science · 12.06.2026 · 9 (6) · 1285-1301
DOI: 10.1021/acsptsci.6c00043 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 16.05.2026. Verfasst von Manisha Nigam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Hemvati Nandan Bahuguna Garhwal University, Srinagar Garhwal, 246174 Uttarakhand, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
High Resolution Image Download MS PowerPoint Slide Breast cancer remains one of the most prevalent malignancies among women worldwide. Current therapeutic strategies comprising surgery, radiation therapy, immunotherapy, and postoperative chemotherapy have significantly improved patient outcomes. However, the emergence of multidrug resistance (MDR) continues to impede treatment efficacy. Several factors contribute to MDR, including drug inactivation, enhanced metabolism, transporter protein-mediated drug efflux, and epigenetic alterations. Among these, the overexpression of drug-metabolizing enzymes such as glutathione S -transferases (GSTs), alongside transporter proteins like the breast cancer resistance protein (BRCA), plays a pivotal role. Numerous studies have demonstrated that GSTs not only accumulate on the cell surface but also interact with proteins involved in critical signaling pathways, thereby enhancing mRNA translation, promoting cell proliferation, and inhibiting apoptosis. These interactions highlight an essential link between GST activity and breast cancer progression. To counter GST-mediated resistance, various GST inhibitors and prodrugs specifically targeting cancer cells with elevated GST expression have been developed, showing considerable therapeutic promise. Nevertheless, the precise molecular mechanisms underlying GST-induced drug resistance remain incompletely understood. A comprehensive understanding of these mechanisms is vital for the rational design of effective therapeutic interventions. Given that breast cancer continues to be the leading cause of cancer-related mortality in women, in-depth exploration of GST’s role in altering the tumor microenvironment (TME), regulating metastasis, and modulating apoptotic pathways is imperative. This review consolidates previous findings and integrates recent experimental evidence, providing a foundational framework for identifying novel GST-related targets in drug design and delivery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Hemvati Nandan Bahuguna Garhwal University, Srinagar Garhwal, 246174 Uttarakhand, India.
- Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.
- Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
- Cosmetics and Natural Products Research Centre (CosNat), Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand.
ORCID-Profile: Abhay Prakash Mishra
Zitieren
APA
Nigam, M., Kukreti, S., Singh, S., & Mishra, A. P. (2026). Unveiling the Role of Glutathione S -transferase Protein in Breast Cancer Drug Resistance: Insights into the Signaling Pathways and Therapeutic Implications. ACS Pharmacology & Translational Science, 9(6), 1285-1301. https://doi.org/10.1021/acsptsci.6c00043
Vancouver
Nigam M, Kukreti S, Singh S, Mishra AP. Unveiling the Role of Glutathione S -transferase Protein in Breast Cancer Drug Resistance: Insights into the Signaling Pathways and Therapeutic Implications. ACS Pharmacology & Translational Science. 2026;9(6):1285-1301. doi:10.1021/acsptsci.6c00043
BibTeX
@article{Nigam2026,
author = {Nigam, Manisha and Kukreti, Shivangi and Singh, Sudarshan and Mishra, Abhay Prakash},
title = {Unveiling the Role of Glutathione S -transferase Protein in Breast Cancer Drug Resistance: Insights into the Signaling Pathways and Therapeutic Implications},
journal = {ACS Pharmacology & Translational Science},
year = {2026},
volume = {9},
number = {6},
pages = {1285--1301},
doi = {10.1021/acsptsci.6c00043}
}
EUVIMED